Miller School Lymphoma Expert Wins Grant for Mantle Cell Lymphoma Research
The Miller School’s Izidore Lossos, M.D., professor of medicine, was among eight lymphoma experts from the U.S. and Europe to receive a Lymphoma Research Foundation (LRF) grant to investigate new treatments for follicular and mantle cell lymphomas.
Lossos, a hematologist-oncologist who joined the Miller School in 2002, received one of the foundation’s $200,000 Mantle Cell Lymphoma Developmental/Exploratory Awards for research into new immunotherapeutic approaches to mantle cell lymphoma.
Diane Blum, the foundation’s chief executive officer, said the awards underscore the foundation’s “commitment to ensuring that the brightest research minds are able to pursue a cure for each of the specific types of lymphoma.’’
Joseph Rosenblatt, M.D., professor of medicine and interim director of Sylvester Comprehensive Cancer Center, said the prestigious award aptly recognizes Lossos’ extensive contributions to the understanding of lymphoma pathogenesis and the quality of his science. “Izidore Lossos has consistently applied science and ingenuity to advancing the treatment of the most difficult lymphomas,’’ Rosenblatt said.
During its recent fall award cycle, the foundation, the nation’s largest non-profit organization devoted to funding innovative lymphoma research, awarded a total of $2.15 million to eight researchers in the U.S. and Europe. Since its inception in 2001, the foundation has awarded more than $47 million in lymphoma-specific research grants. The LRF Scientific Advisory Board, which is composed of the world’s leading lymphoma researchers and oncologists, recommends recipients, who are then approved by the foundation’s board of directors.
“The research supported by these grants will result in a better understanding of the differences among lymphomas, allowing for the development of more effective and less toxic personalized approaches,” said the advisory board chair, Bruce Cheson, M.D., professor of medicine, and deputy chief of hematology and oncology at the Lombardi Comprehensive Cancer Center at Georgetown University Hospital.